Efficacy and safety of the currently recommended regimens with direct acting antiviral(s) (DAA) in the treatment of chronic hepatitis C (CHC) patients in clinical practice. A Greek multicenter real-life cohort study.

被引:0
|
作者
Papatheodoridis, George V. [1 ]
Kapatais, Andreas [2 ]
Goulis, Ioannis [3 ]
Elefsiniotis, Ioannis S. [4 ]
Vlachogiannakos, Jiannis [1 ]
Manolakopoulos, Spilios [5 ]
Dalekos, George N. [6 ,7 ]
Koskinas, John [5 ]
Karatapanis, Stylianos [8 ]
Ketikoglou, Ioannis [5 ]
Deutsch, Melanie [5 ]
Manesis, Emanuel K. [9 ]
Sevastianos, Vassilios A. [10 ]
Schina, Maria J. [11 ]
Triantos, Christos K. [12 ]
Cholongitas, Evangelos [3 ]
Papageorgiou, Maria-Vasiliki [1 ]
Sinakos, Emmanouil [3 ]
Karaoulani, Theofanie [2 ]
Koukoufiki, Argyro [3 ]
Evangelidou, Eftychia [4 ]
Karagiannakis, Dimitrios [1 ]
Kourikou, Anastasia [5 ]
Rigopoulou, Eirini I. [6 ,7 ]
Tampaki, Maria [5 ]
Ntetskas, Georgios [8 ]
Voulgaris, Theodoros [10 ]
Tsolias, Chrysostomos [12 ]
Ioannidou, Panagiota [1 ]
Akriviadis, Evangelos [3 ]
机构
[1] Univ Athens, Laiko Gen Hosp, Dept Gastroenterol, Athens, Greece
[2] Gen Hosp Western Attica Agia Varvara, Gen Hosp Nikaia Piraeus Agios Panteleimon, Piraeus, Greece
[3] Aristotle Univ Thessaloniki, Dept Internal Med 4, Hippokratio Hosp, Thessaloniki, Greece
[4] Gen & Oncol Hosp Kifisia Agioi Anargyroi, Hepatogastroenterol Unit, Univ Dept Internal Med, Athens, Greece
[5] Univ Athens, Hippokratio Gen Hosp, Dept Internal Med 2, Athens, Greece
[6] Univ Thessaly, Sch Med, Dept Med, Larisa, Greece
[7] Univ Thessaly, Sch Med, Res Lab Internal Med, Larisa, Greece
[8] Gen Hosp Rhodes, Dept Internal Med 1, Rhodes, Greece
[9] Euroclinic SA, Liver Unit, Athens, Greece
[10] Evangelismos Gen Hosp, Dept Internal Med 4, Athens, Greece
[11] Evangelismos Gen Hosp, Dept Internal Med 3, Athens, Greece
[12] Univ Hosp Patras, Dept Gastroenterol, Patras, Greece
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1970
引用
收藏
页码:977A / 977A
页数:1
相关论文
共 50 条
  • [31] The impact of direct acting antivirals (DAAs) in patients with decompensated liver disease (DLD) due to chronic hepatitis C (CHC). HERACLIS - a multicenter Greek real world study
    Manolakopoulos, Spilios
    Akriviadis, Evangelos
    Vlachogiannakos, Jiannis
    Papageorgiou, Maria-Vasiliki
    Kapatais, Andreas
    Oikonomopoulou, Martha
    Vasileiadis, Themistoklis G.
    Manesis, Emanuel K.
    Karatapanis, Stylianos
    Deutsch, Melanie
    Triantos, Christos K.
    Dalekos, George N.
    Elefsiniotis, Ioannis S.
    Samonakis, Dimitrios N.
    Alexopoulou, Alexandra
    Sevastianos, Vassilios A.
    Ketikoglou, Ioannis
    Mimidis, Konstantinos
    Koskinas, John
    Ioannidou, Panagiota
    Sinakos, Emmanouil
    Karagiannakis, Dimitrios
    Oikonomou, Theodora
    Karaoulani, Theofanie
    Bellou, Aristea-Lia
    Ntetskas, Georgios
    Tsolias, Chrysostomos
    Rigopoulou, Eirini I.
    Tasovasili, Athanasia
    Koulentaki, Mairi
    Lymberopoulos, Dimitrios V.
    Petalidis, Ioannis
    Mylopoulou, Theodora
    Kranidioti, Hariklia
    Koulias, Emanuel
    Voulgaris, Theodoros
    Cholongitas, Evangelos
    Goulis, Ioannis
    Papatheodoridis, George V.
    HEPATOLOGY, 2017, 66 : 838A - 839A
  • [32] Direct-acting antiviral agents in the treatment of chronic Hepatitis C - "Real-life" experience from an academic centre and two specialized clinical practices
    Gross, Manuel Jonathan
    Haerter, Georg
    Backhus, Johanna
    Zizer, Eugen
    Seufferlein, Thomas
    Ludwig, Leopold
    Dikopoulos, Nektarios
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (04): : 351 - 360
  • [33] THE SAFETY AND EFFICACY OF DIRECT-ACTING ANTIVIRAL TREATMENT FOR PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C AND RENAL IMPAIRMENT
    Furusyo, N.
    Ogawa, E.
    Yamashita, N.
    Kawano, A.
    Takahashi, K.
    Dohmen, K.
    Nakamuta, M.
    Satoh, T.
    Nomura, H.
    Azuma, K.
    Koyanagi, T.
    Kotoh, K.
    Shimoda, S.
    Kajiwara, E.
    Hayashi, J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S801 - S802
  • [34] Efficacy and safety of direct-acting antiviral therapies and baseline predictors for treatment outcomes in hepatitis C patients: A multicenter, real-world study in Guangdong, China
    Xie, Zhiwei
    Deng, Kai
    Xia, Yang
    Zhang, Chunlan
    Xu, Min
    Li, Feng
    Liu, Jinfeng
    Zhou, Yuanping
    Chen, Xiaoping
    Chen, Xuefu
    Yan, Qin
    Huang, Jing
    Chen, Wenli
    Wu, Shuduo
    Bai, Honglian
    Li, Jianping
    Guan, Yujuan
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (09) : 4459 - 4469
  • [35] PATIENT CHARACTERISTICS AND EFFICACY OF PANGENOTYPIC DIRECT-ACTING ANTIVIRAL REGIMENS AMONG A COHORT OF CHRONIC HEPATITIS C PATIENTS RECEIVING ROUTINE CLINICAL CARE IN THE US
    Gordon, Stuart C.
    Li, Jia
    Moorman, Anne C.
    Spradling, Philip R.
    Teshale, Eyasu H.
    Boscarino, Joseph A.
    Daida, Yihe
    Schmidt, Mark A.
    Zhou, Yueren
    Rupp, Loralee B.
    Trudeau, Sheri
    Lu, Mei
    HEPATOLOGY, 2020, 72 : 540A - 541A
  • [36] Safety and efficacy of direct-acting antiviral drugs in the treatment of chronic hepatitis C virus infection in patients with thalassemia: a prospective study
    Ghoneem, Elsayed
    Saleh, Ahmed
    El-Etreby, Shahira Aly
    Mortada, Metwaly Ibrahim
    Ghannam, Mayada A.
    El-Ashwah, Shaimaa
    Eisa, Noha
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)
  • [37] Safety and efficacy of direct-acting antiviral drugs in the treatment of chronic hepatitis C virus infection in patients with thalassemia: a prospective study
    Elsayed Ghoneem
    Ahmed Saleh
    Shahira Aly El-Etreby
    Metwaly Ibrahim Mortada
    Mayada A. Ghannam
    Shaimaa El-Ashwah
    Noha Eisa
    Egyptian Liver Journal, 11
  • [38] GLOBAL TREATMENT RATE AND BARRIERS TO DIRECT ACTING ANTIVIRAL (DAA) TREATMENT OF CHRONIC HEPATITIS C (CHC): A SYSTEMATIC REVIEW AND META-ANALYSIS OF 179 STUDIES AND 2,421,347 CHC PATIENTS
    Nguyen, Vy H.
    Tan, Darren Jun Hao
    Jin, Michelle
    Lee, Eunice Y.
    Nerurkar, Sanjna N.
    Huang, Daniel
    Ogawa, Eiichi
    Thin, Khin Naing
    Teng, Margaret
    Goh, Kang Shiong
    Le, Thuy T.
    Hai, Hoang
    Nguyen, Mindie H.
    HEPATOLOGY, 2022, 76 : S371 - S372
  • [39] Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients
    Garioud, Armand
    Heng, Ratmony
    Amiot, Xavier
    Remy, Andre-Jean
    Ollivier-Hourmand, Isabelle
    Mokhtari, Camelia
    Medmoun, Mourad
    Renou, Christophe
    Zougmore, Honore
    Pulwermacher, Philippe
    Lucidarme, Damien
    Rosa-Hezode, Isabelle
    Causse, Xavier
    Arotcarena, Ramuntcho
    Zanditenas, David
    Halfon, Philippe
    Pariente, Alexandre
    Cadranel, Jean-Francois
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (10) : 1270 - 1274
  • [40] Treatment of Chronic Hepatitis C infection with Directly Acting Antiviral (DAA) drugs in Children with Transfusion Dependent Thalassemia (TDT): A real life study
    Singh, Shivaram Prasad
    Barik, Rakesh Kumar
    Sahu, Saroj Kanta
    Pradhan, Subhasis
    Khatua, Chitta Ranjan
    Mishra, Debakanta
    Panigrahi, Subhendu
    Meher, Dinesh
    Khandelwal, Reshu
    Nath, Gautam
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 277 - 277